首页 > 最新文献

Journal of Intensive Care最新文献

英文 中文
Correlation between tissue Doppler-derived left ventricular systolic velocity (S') and left ventricle ejection fraction in sepsis and septic shock: a retrospective cohort study. 脓毒症和感染性休克患者组织多普勒衍生左心室收缩速度(S’)和左心室射血分数的相关性:一项回顾性队列研究
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-07-03 DOI: 10.1186/s40560-023-00678-z
Sanchit Chawla, Ryota Sato, Abhijit Duggal, Mahmoud Alwakeel, Daisuke Hasegawa, Dina Alayan, Patrick Collier, Filippo Sanfilippo, Michael Lanspa, Siddharth Dugar

Background: Tissue Doppler-derived left ventricular systolic velocity (mitral S') has shown excellent correlation to left ventricular ejection fraction (LVEF) in non-critically patients. However, their correlation in septic patients remains poorly understood and its impact on mortality is undetermined. We investigated the relationship between mitral S' and LVEF in a large cohort of critically-ill septic patients.

Methods: We conducted a retrospective cohort study between 01/2011 and 12/2020. All adult patients (≥ 18 years) who were admitted to the medical intensive care unit (MICU) with sepsis and septic shock that underwent a transthoracic echocardiogram (TTE) within 72 h were included. Pearson correlation test was used to assess correlation between average mitral S' and LVEF. Pearson correlation was used to assess correlation between average mitral S' and LVEF. We also assessed the association between mitral S', LVEF and 28-day mortality.

Results: 2519 patients met the inclusion criteria. The study population included 1216 (48.3%) males with a median age of 64 (IQR: 53-73), and a median APACHE III score of 85 (IQR: 67, 108). The median septal, lateral, and average mitral S' were 8 cm/s (IQR): 6.0, 10.0], 9 cm/s (IQR: 6.0, 10.0), and 8.5 cm/s (IQR: 6.5, 10.5), respectively. Mitral S' was noted to have moderate correlation with LVEF (r = 0.46). In multivariable logistic regression analysis, average mitral S' was associated with an increase in both 28-day ICU and in-hospital mortality with odds ratio (OR) 1.04 (95% CI 1.01-1.08, p = 0.02) and OR 1.04 (95% CI 1.01-1.07, p = 0.02), respectively.

Conclusions: Even though mitral S' and LVEF may be related, they are not exchangeable and were only found to have moderate correlation in this study. LVEF is U-shaped, while mitral S' has a linear relation with 28-day ICU mortality. An increase in average mitral S' was associated with higher 28-day mortality.

背景:组织多普勒衍生的左心室收缩速度(二尖瓣S')与非危重患者左心室射血分数(LVEF)有很好的相关性。然而,它们在脓毒症患者中的相关性仍然知之甚少,其对死亡率的影响尚不确定。我们研究了一大批重症脓毒症患者二尖瓣S'和LVEF之间的关系。方法:2011年1月至2020年12月进行回顾性队列研究。所有因脓毒症和脓毒性休克入住医学重症监护病房(MICU)并在72小时内接受经胸超声心动图(TTE)检查的成年患者(≥18岁)均被纳入研究。采用Pearson相关检验评价二尖瓣平均S′与LVEF的相关性。采用Pearson相关性评价二尖瓣平均S′与LVEF的相关性。我们还评估了二尖瓣S′、LVEF与28天死亡率之间的关系。结果:2519例患者符合纳入标准。研究人群包括1216名男性(48.3%),中位年龄64岁(IQR: 53-73),中位APACHE III评分为85 (IQR: 67, 108)。中间隔、侧二尖瓣和平均二尖瓣S′分别为8 cm/ S (IQR): 6.0、10.0,9 cm/ S (IQR: 6.0、10.0)和8.5 cm/ S (IQR: 6.5、10.5)。二尖瓣S′与LVEF有中度相关性(r = 0.46)。在多变量logistic回归分析中,平均二尖瓣S′与28天ICU和住院死亡率的增加相关,比值比(OR)分别为1.04 (95% CI 1.01-1.08, p = 0.02)和1.04 (95% CI 1.01-1.07, p = 0.02)。结论:尽管二尖瓣S′与LVEF可能存在相关性,但两者并不具有互换性,本研究仅发现两者存在中度相关性。LVEF呈u型,二尖瓣S′与28天ICU死亡率呈线性关系。二尖瓣S′平均升高与28天死亡率升高有关。
{"title":"Correlation between tissue Doppler-derived left ventricular systolic velocity (S') and left ventricle ejection fraction in sepsis and septic shock: a retrospective cohort study.","authors":"Sanchit Chawla,&nbsp;Ryota Sato,&nbsp;Abhijit Duggal,&nbsp;Mahmoud Alwakeel,&nbsp;Daisuke Hasegawa,&nbsp;Dina Alayan,&nbsp;Patrick Collier,&nbsp;Filippo Sanfilippo,&nbsp;Michael Lanspa,&nbsp;Siddharth Dugar","doi":"10.1186/s40560-023-00678-z","DOIUrl":"https://doi.org/10.1186/s40560-023-00678-z","url":null,"abstract":"<p><strong>Background: </strong>Tissue Doppler-derived left ventricular systolic velocity (mitral S') has shown excellent correlation to left ventricular ejection fraction (LVEF) in non-critically patients. However, their correlation in septic patients remains poorly understood and its impact on mortality is undetermined. We investigated the relationship between mitral S' and LVEF in a large cohort of critically-ill septic patients.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study between 01/2011 and 12/2020. All adult patients (≥ 18 years) who were admitted to the medical intensive care unit (MICU) with sepsis and septic shock that underwent a transthoracic echocardiogram (TTE) within 72 h were included. Pearson correlation test was used to assess correlation between average mitral S' and LVEF. Pearson correlation was used to assess correlation between average mitral S' and LVEF. We also assessed the association between mitral S', LVEF and 28-day mortality.</p><p><strong>Results: </strong>2519 patients met the inclusion criteria. The study population included 1216 (48.3%) males with a median age of 64 (IQR: 53-73), and a median APACHE III score of 85 (IQR: 67, 108). The median septal, lateral, and average mitral S' were 8 cm/s (IQR): 6.0, 10.0], 9 cm/s (IQR: 6.0, 10.0), and 8.5 cm/s (IQR: 6.5, 10.5), respectively. Mitral S' was noted to have moderate correlation with LVEF (r = 0.46). In multivariable logistic regression analysis, average mitral S' was associated with an increase in both 28-day ICU and in-hospital mortality with odds ratio (OR) 1.04 (95% CI 1.01-1.08, p = 0.02) and OR 1.04 (95% CI 1.01-1.07, p = 0.02), respectively.</p><p><strong>Conclusions: </strong>Even though mitral S' and LVEF may be related, they are not exchangeable and were only found to have moderate correlation in this study. LVEF is U-shaped, while mitral S' has a linear relation with 28-day ICU mortality. An increase in average mitral S' was associated with higher 28-day mortality.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9750881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organ dysfunction, injury, and failure in cardiogenic shock. 心源性休克中的器官功能障碍、损伤和衰竭。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-06-29 DOI: 10.1186/s40560-023-00676-1
Akihiro Shirakabe, Masato Matsushita, Yusaku Shibata, Shota Shighihara, Suguru Nishigoori, Tomofumi Sawatani, Kazutaka Kiuchi, Kuniya Asai

Background: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance).

Main body: Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output ("forward failure") to venous congestion ("backward failure") as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure.

Conclusions: Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS.

背景:心源性休克(CS)是由原发性心功能障碍引起的,由多种异质疾病引起(如急性心脏功能障碍,或急性或慢性心脏功能障碍)。主体:虽然低心脏指数在CS患者中很常见,但不同患者的心室预负荷、肺毛细血管楔压、中心静脉压和全身血管阻力可能不同。器官功能障碍传统上被认为是由于心输出量的进行性损害或继发于CS的血管内容量耗竭而导致的器官灌注不足。然而,最近的研究注意力已经从心输出量(“前向衰竭”)转移到静脉充血(“后向衰竭”),认为这是最重要的血流动力学决定因素。CS引起的灌注不足和/或静脉充血均可导致靶器官(即心、肺、肾、肝、肠、脑)的损伤、损害和衰竭;这些影响与死亡率增加有关。预防、减少和逆转器官损伤的治疗策略是必要的,以提高这些患者的发病率。本文综述了最近关于器官功能障碍、损伤和衰竭的资料。结论:早期识别和治疗器官功能障碍以及血流动力学稳定是CS患者管理的关键组成部分。
{"title":"Organ dysfunction, injury, and failure in cardiogenic shock.","authors":"Akihiro Shirakabe,&nbsp;Masato Matsushita,&nbsp;Yusaku Shibata,&nbsp;Shota Shighihara,&nbsp;Suguru Nishigoori,&nbsp;Tomofumi Sawatani,&nbsp;Kazutaka Kiuchi,&nbsp;Kuniya Asai","doi":"10.1186/s40560-023-00676-1","DOIUrl":"https://doi.org/10.1186/s40560-023-00676-1","url":null,"abstract":"<p><strong>Background: </strong>Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance).</p><p><strong>Main body: </strong>Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (\"forward failure\") to venous congestion (\"backward failure\") as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure.</p><p><strong>Conclusions: </strong>Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9793010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stomach position evaluated using computed tomography is related to successful post-pyloric enteral feeding tube placement in critically ill patients: a retrospective observational study. 一项回顾性观察研究:使用计算机断层扫描评估胃位置与危重患者幽门后肠内喂养管置入成功相关。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-30 DOI: 10.1186/s40560-023-00673-4
Masashi Yokose, Shunsuke Takaki, Yusuke Saigusa, Takahiro Mihara, Yoshinobu Ishiwata, Shingo Kato, Keiichi Horie, Takahisa Goto

Background: Post-pyloric enteral feeding reduces respiratory complications and shortens the duration of mechanical ventilation. Blind placement of post-pyloric enteral feeding tubes (EFT) in patients with critical illnesses is often the first-line method because endoscopy or fluoroscopy cannot be easily performed at bedside; however, difficult placements regularly occur. We reported an association between the stomach position caudal to spinal level L1-L2, evaluated by abdominal radiographs after placement, and difficult placement; however, this method could not indicate difficulty before EFT placement. The aim of our study was to evaluate the association between stomach position, estimated using computed tomography (CT) images taken before the blind placement of the post-pyloric EFT, and the difficulty of EFT placement.

Methods: Data from patients aged ≥ 20 years who underwent post-pyloric EFT in our intensive care unit were obtained retrospectively. Logistic regression analysis was used to evaluate the association between successful initial EFT placement and explanatory variables, including stomach position estimated by CT. Two cut-off values were used: caudal to L1-L2 based on a previous study and the best cut-off value calculated by the receiver operating characteristic curve. Variable selection was performed backward stepwise using Akaike's Information Criterion.

Results: Of the total of 453 patients who were enrolled, the success rate of the initial EFT placement was 43.5%. The adjusted odds ratio for successful initial EFT placement of the stomach position caudal to L1-L2 was 0.61 (95% confidence interval: 0.41-1.07). Logistic regression analysis, including the stomach position caudal to L2-L3, calculated as the best cut-off value, indicated that stomach position was an independent factor for failure of initial EFT placement (adjusted odds ratio, 0.55; 95% confidence interval: 0.33-0.91).

Conclusions: Stomach position evaluated using CT images was associated with successful initial post-pyloric EFT placement. The best cut-off value of the greater curvature of the stomach to predict the success or failure of the first attempt was spinal level L2-L3. Trial registration University Hospital Medical Information Network Clinical Trials Registry (UMIN000046986; February 28, 2022). https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000052151.

背景:幽门后肠内喂养可减少呼吸并发症,缩短机械通气时间。对于危重疾病患者,盲置幽门后肠内喂养管(EFT)通常是一线方法,因为内窥镜或透视镜不容易在床边进行;然而,困难的安置经常发生。我们报道了放置后腹部x线片评估的胃位置从尾侧到脊柱水平L1-L2与放置困难之间的关联;然而,这种方法不能在EFT放置前显示难度。我们研究的目的是评估胃位置(在幽门后EFT盲放置前使用计算机断层扫描(CT)图像估计)与EFT放置难度之间的关系。方法:回顾性分析我院重症监护室年龄≥20岁的幽门后EFT患者的资料。采用Logistic回归分析评估EFT初始放置成功与解释变量(包括CT估计的胃位置)之间的关系。采用两个截止值:基于前人研究的L1-L2尾端和由受者工作特征曲线计算的最佳截止值。采用赤池信息准则逐步进行变量选择。结果:纳入的453例患者中,EFT初始放置成功率为43.5%。在L1-L2尾侧胃位成功初始EFT放置的优势比为0.61(95%可信区间:0.41-1.07)。Logistic回归分析,包括胃位置在L2-L3的尾端,计算为最佳截断值,表明胃位置是初始EFT放置失败的独立因素(校正优势比,0.55;95%置信区间:0.33-0.91)。结论:使用CT图像评估胃位置与幽门后EFT初始放置成功相关。预测第一次手术成功或失败的最佳临界值是脊柱L2-L3节段。大学医院医学信息网临床试验注册(UMIN000046986;2022年2月28日)。https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000052151。
{"title":"Stomach position evaluated using computed tomography is related to successful post-pyloric enteral feeding tube placement in critically ill patients: a retrospective observational study.","authors":"Masashi Yokose,&nbsp;Shunsuke Takaki,&nbsp;Yusuke Saigusa,&nbsp;Takahiro Mihara,&nbsp;Yoshinobu Ishiwata,&nbsp;Shingo Kato,&nbsp;Keiichi Horie,&nbsp;Takahisa Goto","doi":"10.1186/s40560-023-00673-4","DOIUrl":"https://doi.org/10.1186/s40560-023-00673-4","url":null,"abstract":"<p><strong>Background: </strong>Post-pyloric enteral feeding reduces respiratory complications and shortens the duration of mechanical ventilation. Blind placement of post-pyloric enteral feeding tubes (EFT) in patients with critical illnesses is often the first-line method because endoscopy or fluoroscopy cannot be easily performed at bedside; however, difficult placements regularly occur. We reported an association between the stomach position caudal to spinal level L1-L2, evaluated by abdominal radiographs after placement, and difficult placement; however, this method could not indicate difficulty before EFT placement. The aim of our study was to evaluate the association between stomach position, estimated using computed tomography (CT) images taken before the blind placement of the post-pyloric EFT, and the difficulty of EFT placement.</p><p><strong>Methods: </strong>Data from patients aged ≥ 20 years who underwent post-pyloric EFT in our intensive care unit were obtained retrospectively. Logistic regression analysis was used to evaluate the association between successful initial EFT placement and explanatory variables, including stomach position estimated by CT. Two cut-off values were used: caudal to L1-L2 based on a previous study and the best cut-off value calculated by the receiver operating characteristic curve. Variable selection was performed backward stepwise using Akaike's Information Criterion.</p><p><strong>Results: </strong>Of the total of 453 patients who were enrolled, the success rate of the initial EFT placement was 43.5%. The adjusted odds ratio for successful initial EFT placement of the stomach position caudal to L1-L2 was 0.61 (95% confidence interval: 0.41-1.07). Logistic regression analysis, including the stomach position caudal to L2-L3, calculated as the best cut-off value, indicated that stomach position was an independent factor for failure of initial EFT placement (adjusted odds ratio, 0.55; 95% confidence interval: 0.33-0.91).</p><p><strong>Conclusions: </strong>Stomach position evaluated using CT images was associated with successful initial post-pyloric EFT placement. The best cut-off value of the greater curvature of the stomach to predict the success or failure of the first attempt was spinal level L2-L3. Trial registration University Hospital Medical Information Network Clinical Trials Registry (UMIN000046986; February 28, 2022). https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000052151.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9605867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-intensive care syndrome (PICS): recent updates. 重症监护后综合征(PICS):最新进展。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-23 DOI: 10.1186/s40560-023-00670-7
Stephanie L Hiser, Arooj Fatima, Mazin Ali, Dale M Needham

An increasing number of patients are surviving critical illness, but some experience new or worsening long-lasting impairments in physical, cognitive and/or mental health, commonly known as post-intensive care syndrome (PICS). The need to better understand and improve PICS has resulted in a growing body of literature exploring its various facets. This narrative review will focus on recent studies evaluating various aspects of PICS, including co-occurrence of specific impairments, subtypes/phenotypes, risk factors/mechanisms, and interventions. In addition, we highlight new aspects of PICS, including long-term fatigue, pain, and unemployment.

越来越多的患者在危重疾病中幸存下来,但一些患者在身体、认知和/或精神健康方面出现新的或恶化的长期损伤,通常称为重症监护后综合征(PICS)。为了更好地理解和改进PICS,越来越多的文献开始探索PICS的各个方面。这篇叙述性综述将集中在评估PICS的各个方面的最新研究,包括共同发生的特定损伤、亚型/表型、危险因素/机制和干预措施。此外,我们强调了PICS的新方面,包括长期疲劳,疼痛和失业。
{"title":"Post-intensive care syndrome (PICS): recent updates.","authors":"Stephanie L Hiser,&nbsp;Arooj Fatima,&nbsp;Mazin Ali,&nbsp;Dale M Needham","doi":"10.1186/s40560-023-00670-7","DOIUrl":"https://doi.org/10.1186/s40560-023-00670-7","url":null,"abstract":"<p><p>An increasing number of patients are surviving critical illness, but some experience new or worsening long-lasting impairments in physical, cognitive and/or mental health, commonly known as post-intensive care syndrome (PICS). The need to better understand and improve PICS has resulted in a growing body of literature exploring its various facets. This narrative review will focus on recent studies evaluating various aspects of PICS, including co-occurrence of specific impairments, subtypes/phenotypes, risk factors/mechanisms, and interventions. In addition, we highlight new aspects of PICS, including long-term fatigue, pain, and unemployment.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. 脓毒症相关弥散性血管内凝血的病理生理学、诊断和治疗。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-23 DOI: 10.1186/s40560-023-00672-5
Toshiaki Iba, Julie Helms, Jean Marie Connors, Jerrold H Levy

Background: The International Society on Thrombosis and Haemostasis (ISTH) released overt disseminated intravascular coagulation (DIC) diagnostic criteria in 2001. Since then, DIC has been understood as the end-stage consumptive coagulopathy and not the therapeutic target. However, DIC is not merely a decompensated coagulation disorder, but also includes early stages with systemic activation in coagulation. Thus, the ISTH has recently released sepsis-induced coagulopathy (SIC) criteria that can diagnose compensated-phase of coagulopathy with readily available biomarkers.

Main body: DIC is a laboratory-based diagnosis due to various critical conditions, although sepsis is the most common underlying disease. The pathophysiology of sepsis-associated DIC is multifactorial, and in addition to coagulation activation with suppressed fibrinolysis, multiple inflammatory responses are initiated by activated leukocytes, platelets, and vascular endothelial cells as part of thromboinflammation. Although overt DIC diagnostic criteria were established by ISTH to diagnose the advanced stage of DIC, additional criteria that can detect an earlier stage of DIC were needed for potential therapeutic considerations. Accordingly, the ISTH introduced SIC criteria in 2019 that are easy to use and require only platelet count, prothrombin time-international normalized ratio, and Sequential Organ Failure Assessment Score. SIC score can be used to evaluate disease severity and determine the timing of potential therapeutic interventions. One of the major disadvantages in treating sepsis-associated DIC is the lack of availability of specific therapeutic approaches beyond treating the underlying infection. Clinical trials to date have failed because included patients who were not coagulopathic. Nevertheless, in addition to infection control, anticoagulant therapy will be the choice for sepsis-associated DIC. Therefore, the efficacy of heparin, antithrombin, and recombinant thrombomodulin has to be proven in future clinical studies.

Conclusion: It is necessary to develop a novel therapeutic strategy against sepsis-associated DIC and improve the outcomes. Consequently, we recommend screening and monitoring DIC using SIC scoring system.

背景:国际血栓与止血学会(ISTH)于2001年发布了明显弥散性血管内凝血(DIC)诊断标准。从那时起,DIC被理解为终末期消耗性凝血病,而不是治疗目标。然而,DIC不仅仅是一种失代偿性凝血障碍,还包括凝血系统激活的早期阶段。因此,ISTH最近发布了脓毒症诱导凝血病(SIC)标准,可以用现成的生物标志物诊断代偿期凝血病。主体:DIC是一种基于实验室的诊断,由于各种危急情况,尽管败血症是最常见的基础疾病。脓毒症相关DIC的病理生理是多因素的,除了抑制纤维蛋白溶解的凝血激活外,多种炎症反应是由活化的白细胞、血小板和血管内皮细胞发起的,作为血栓炎症的一部分。虽然ISTH建立了明显的DIC诊断标准来诊断DIC的晚期,但需要额外的标准来检测DIC的早期阶段,以考虑潜在的治疗。因此,ISTH于2019年引入了易于使用的SIC标准,仅需要血小板计数、凝血酶原时间-国际标准化比率和序贯器官衰竭评估评分。SIC评分可用于评估疾病严重程度和确定潜在治疗干预的时机。治疗脓毒症相关DIC的主要缺点之一是除了治疗潜在感染之外缺乏特异性治疗方法。迄今为止的临床试验都失败了,因为包括了没有凝血障碍的患者。然而,除了感染控制,抗凝治疗将是脓毒症相关DIC的选择。因此,肝素、抗凝血酶和重组凝血调节蛋白的疗效有待于在未来的临床研究中进一步验证。结论:有必要开发一种新的治疗策略来治疗败血症相关性DIC,并改善预后。因此,我们建议使用SIC评分系统筛选和监测DIC。
{"title":"The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.","authors":"Toshiaki Iba,&nbsp;Julie Helms,&nbsp;Jean Marie Connors,&nbsp;Jerrold H Levy","doi":"10.1186/s40560-023-00672-5","DOIUrl":"https://doi.org/10.1186/s40560-023-00672-5","url":null,"abstract":"<p><strong>Background: </strong>The International Society on Thrombosis and Haemostasis (ISTH) released overt disseminated intravascular coagulation (DIC) diagnostic criteria in 2001. Since then, DIC has been understood as the end-stage consumptive coagulopathy and not the therapeutic target. However, DIC is not merely a decompensated coagulation disorder, but also includes early stages with systemic activation in coagulation. Thus, the ISTH has recently released sepsis-induced coagulopathy (SIC) criteria that can diagnose compensated-phase of coagulopathy with readily available biomarkers.</p><p><strong>Main body: </strong>DIC is a laboratory-based diagnosis due to various critical conditions, although sepsis is the most common underlying disease. The pathophysiology of sepsis-associated DIC is multifactorial, and in addition to coagulation activation with suppressed fibrinolysis, multiple inflammatory responses are initiated by activated leukocytes, platelets, and vascular endothelial cells as part of thromboinflammation. Although overt DIC diagnostic criteria were established by ISTH to diagnose the advanced stage of DIC, additional criteria that can detect an earlier stage of DIC were needed for potential therapeutic considerations. Accordingly, the ISTH introduced SIC criteria in 2019 that are easy to use and require only platelet count, prothrombin time-international normalized ratio, and Sequential Organ Failure Assessment Score. SIC score can be used to evaluate disease severity and determine the timing of potential therapeutic interventions. One of the major disadvantages in treating sepsis-associated DIC is the lack of availability of specific therapeutic approaches beyond treating the underlying infection. Clinical trials to date have failed because included patients who were not coagulopathic. Nevertheless, in addition to infection control, anticoagulant therapy will be the choice for sepsis-associated DIC. Therefore, the efficacy of heparin, antithrombin, and recombinant thrombomodulin has to be proven in future clinical studies.</p><p><strong>Conclusion: </strong>It is necessary to develop a novel therapeutic strategy against sepsis-associated DIC and improve the outcomes. Consequently, we recommend screening and monitoring DIC using SIC scoring system.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9522320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Fundamental concepts and the latest evidence for esophageal pressure monitoring. 食管压力监测的基本概念和最新证据。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-22 DOI: 10.1186/s40560-023-00671-6
Tatsutoshi Shimatani, Miyako Kyogoku, Yukie Ito, Muneyuki Takeuchi, Robinder G Khemani

Transpulmonary pressure is an essential physiologic concept as it reflects the true pressure across the alveoli, and is a more precise marker for lung stress. To calculate transpulmonary pressure, one needs an estimate of both alveolar pressure and pleural pressure. Airway pressure during conditions of no flow is the most widely accepted surrogate for alveolar pressure, while esophageal pressure remains the most widely measured surrogate marker for pleural pressure. This review will cover important concepts and clinical applications for esophageal manometry, with a particular focus on how to use the information from esophageal manometry to adjust or titrate ventilator support. The most widely used method for measuring esophageal pressure uses an esophageal balloon catheter, although these measurements can be affected by the volume of air in the balloon. Therefore, when using balloon catheters, it is important to calibrate the balloon to ensure the most appropriate volume of air, and we discuss several methods which have been proposed for balloon calibration. In addition, esophageal balloon catheters only estimate the pleural pressure over a certain area within the thoracic cavity, which has resulted in a debate regarding how to interpret these measurements. We discuss both direct and elastance-based methods to estimate transpulmonary pressure, and how they may be applied for clinical practice. Finally, we discuss a number of applications for esophageal manometry and review many of the clinical studies published to date which have used esophageal pressure. These include the use of esophageal pressure to assess lung and chest wall compliance individually which can provide individualized information for patients with acute respiratory failure in terms of setting PEEP, or limiting inspiratory pressure. In addition, esophageal pressure has been used to estimate effort of breathing which has application for ventilator weaning, detection of upper airway obstruction after extubation, and detection of patient and mechanical ventilator asynchrony.

跨肺压是一个重要的生理学概念,因为它反映了肺泡的真实压力,是肺应激的更精确的标志。为了计算肺压,我们需要估计肺泡压和胸膜压。无血流状态下的气道压力是最广泛接受的肺泡压力替代指标,而食管压力仍然是最广泛测量的胸膜压力替代指标。这篇综述将涵盖食道压力测量的重要概念和临床应用,特别关注如何使用食道压力测量的信息来调整或滴定呼吸机支持。最广泛使用的测量食管压力的方法是使用食管球囊导管,尽管这些测量结果会受到球囊内空气量的影响。因此,在使用球囊导管时,校准球囊以确保最合适的空气量是很重要的,我们讨论了几种已经提出的球囊校准方法。此外,食道球囊导管只能估计胸腔内一定区域的胸膜压力,这导致了关于如何解释这些测量结果的争论。我们讨论了直接和基于弹性的方法来估计跨肺压力,以及它们如何应用于临床实践。最后,我们讨论了食道压力测量的一些应用,并回顾了迄今为止发表的许多使用食道压力的临床研究。其中包括使用食道压力单独评估肺和胸壁顺应性,这可以为急性呼吸衰竭患者提供个性化的信息,例如设定PEEP或限制吸气压力。此外,食管压力被用来估计呼吸的努力,应用于呼吸机脱机、拔管后上呼吸道阻塞的检测以及患者与机械呼吸机不同步的检测。
{"title":"Fundamental concepts and the latest evidence for esophageal pressure monitoring.","authors":"Tatsutoshi Shimatani,&nbsp;Miyako Kyogoku,&nbsp;Yukie Ito,&nbsp;Muneyuki Takeuchi,&nbsp;Robinder G Khemani","doi":"10.1186/s40560-023-00671-6","DOIUrl":"https://doi.org/10.1186/s40560-023-00671-6","url":null,"abstract":"<p><p>Transpulmonary pressure is an essential physiologic concept as it reflects the true pressure across the alveoli, and is a more precise marker for lung stress. To calculate transpulmonary pressure, one needs an estimate of both alveolar pressure and pleural pressure. Airway pressure during conditions of no flow is the most widely accepted surrogate for alveolar pressure, while esophageal pressure remains the most widely measured surrogate marker for pleural pressure. This review will cover important concepts and clinical applications for esophageal manometry, with a particular focus on how to use the information from esophageal manometry to adjust or titrate ventilator support. The most widely used method for measuring esophageal pressure uses an esophageal balloon catheter, although these measurements can be affected by the volume of air in the balloon. Therefore, when using balloon catheters, it is important to calibrate the balloon to ensure the most appropriate volume of air, and we discuss several methods which have been proposed for balloon calibration. In addition, esophageal balloon catheters only estimate the pleural pressure over a certain area within the thoracic cavity, which has resulted in a debate regarding how to interpret these measurements. We discuss both direct and elastance-based methods to estimate transpulmonary pressure, and how they may be applied for clinical practice. Finally, we discuss a number of applications for esophageal manometry and review many of the clinical studies published to date which have used esophageal pressure. These include the use of esophageal pressure to assess lung and chest wall compliance individually which can provide individualized information for patients with acute respiratory failure in terms of setting PEEP, or limiting inspiratory pressure. In addition, esophageal pressure has been used to estimate effort of breathing which has application for ventilator weaning, detection of upper airway obstruction after extubation, and detection of patient and mechanical ventilator asynchrony.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9503255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial. 头盔无创通气与高流量鼻吸氧治疗COVID-19患者的长期疗效:一项随机试验
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-19 DOI: 10.1186/s40560-023-00669-0
Teresa Michi, Chiara Mattana, Luca S Menga, Maria Grazia Bocci, Melania Cesarano, Tommaso Rosà, Maria Rosaria Gualano, Jonathan Montomoli, Savino Spadaro, Matteo Tosato, Elisabetta Rota, Francesco Landi, Salvatore L Cutuli, Eloisa S Tanzarella, Gabriele Pintaudi, Edoardo Piervincenzi, Giuseppe Bello, Tommaso Tonetti, Paola Rucci, Gennaro De Pascale, Salvatore M Maggiore, Domenico Luca Grieco, Giorgio Conti, Massimo Antonelli

Background: Long-term outcomes of patients treated with helmet noninvasive ventilation (NIV) are unknown: safety concerns regarding the risk of patient self-inflicted lung injury and delayed intubation exist when NIV is applied in hypoxemic patients. We assessed the 6-month outcome of patients who received helmet NIV or high-flow nasal oxygen for COVID-19 hypoxemic respiratory failure.

Methods: In this prespecified analysis of a randomized trial of helmet NIV versus high-flow nasal oxygen (HENIVOT), clinical status, physical performance (6-min-walking-test and 30-s chair stand test), respiratory function and quality of life (EuroQoL five dimensions five levels questionnaire, EuroQoL VAS, SF36 and Post-Traumatic Stress Disorder Checklist for the DSM) were evaluated 6 months after the enrollment.

Results: Among 80 patients who were alive, 71 (89%) completed the follow-up: 35 had received helmet NIV, 36 high-flow oxygen. There was no inter-group difference in any item concerning vital signs (N = 4), physical performance (N = 18), respiratory function (N = 27), quality of life (N = 21) and laboratory tests (N = 15). Arthralgia was significantly lower in the helmet group (16% vs. 55%, p = 0.002). Fifty-two percent of patients in helmet group vs. 63% of patients in high-flow group had diffusing capacity of the lungs for carbon monoxide < 80% of predicted (p = 0.44); 13% vs. 22% had forced vital capacity < 80% of predicted (p = 0.51). Both groups reported similar degree of pain (p = 0.81) and anxiety (p = 0.81) at the EQ-5D-5L test; the EQ-VAS score was similar in the two groups (p = 0.27). Compared to patients who successfully avoided invasive mechanical ventilation (54/71, 76%), intubated patients (17/71, 24%) had significantly worse pulmonary function (median diffusing capacity of the lungs for carbon monoxide 66% [Interquartile range: 47-77] of predicted vs. 80% [71-88], p = 0.005) and decreased quality of life (EQ-VAS: 70 [53-70] vs. 80 [70-83], p = 0.01).

Conclusions: In patients with COVID-19 hypoxemic respiratory failure, treatment with helmet NIV or high-flow oxygen yielded similar quality of life and functional outcome at 6 months. The need for invasive mechanical ventilation was associated with worse outcomes. These data indicate that helmet NIV, as applied in the HENIVOT trial, can be safely used in hypoxemic patients. Trial registration Registered on clinicaltrials.gov NCT04502576 on August 6, 2020.

背景:头盔无创通气(NIV)治疗患者的长期结果尚不清楚:当低氧血症患者应用无创通气时,存在有关患者自身肺损伤风险和延迟插管的安全问题。我们评估了接受头盔NIV或高流量鼻吸氧治疗COVID-19低氧性呼吸衰竭患者的6个月结局。方法:在这项预先指定的随机试验中,对头盔NIV与高流量鼻氧(HENIVOT)进行分析,在入组6个月后评估临床状态、身体表现(6分钟步行测试和30秒椅子站立测试)、呼吸功能和生活质量(EuroQoL五维度五水平问卷、EuroQoL VAS、SF36和DSM创伤后应激障碍检查表)。结果:80例存活患者中,71例(89%)完成随访,35例接受头盔NIV, 36例接受高流量氧气。生命体征(N = 4)、体能(N = 18)、呼吸功能(N = 27)、生活质量(N = 21)、实验室检查(N = 15)各项指标组间差异无统计学意义。关节痛明显低于头盔组(16%比55%,p = 0.002)。结论:在COVID-19低氧性呼吸衰竭患者中,使用头盔NIV或高流量氧气治疗6个月时的生活质量和功能结果相似。需要有创机械通气与较差的预后相关。这些数据表明,HENIVOT试验中使用的头盔NIV可以安全地用于低氧血症患者。试验注册于2020年8月6日在clinicaltrials.gov注册,编号NCT04502576。
{"title":"Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial.","authors":"Teresa Michi,&nbsp;Chiara Mattana,&nbsp;Luca S Menga,&nbsp;Maria Grazia Bocci,&nbsp;Melania Cesarano,&nbsp;Tommaso Rosà,&nbsp;Maria Rosaria Gualano,&nbsp;Jonathan Montomoli,&nbsp;Savino Spadaro,&nbsp;Matteo Tosato,&nbsp;Elisabetta Rota,&nbsp;Francesco Landi,&nbsp;Salvatore L Cutuli,&nbsp;Eloisa S Tanzarella,&nbsp;Gabriele Pintaudi,&nbsp;Edoardo Piervincenzi,&nbsp;Giuseppe Bello,&nbsp;Tommaso Tonetti,&nbsp;Paola Rucci,&nbsp;Gennaro De Pascale,&nbsp;Salvatore M Maggiore,&nbsp;Domenico Luca Grieco,&nbsp;Giorgio Conti,&nbsp;Massimo Antonelli","doi":"10.1186/s40560-023-00669-0","DOIUrl":"https://doi.org/10.1186/s40560-023-00669-0","url":null,"abstract":"<p><strong>Background: </strong>Long-term outcomes of patients treated with helmet noninvasive ventilation (NIV) are unknown: safety concerns regarding the risk of patient self-inflicted lung injury and delayed intubation exist when NIV is applied in hypoxemic patients. We assessed the 6-month outcome of patients who received helmet NIV or high-flow nasal oxygen for COVID-19 hypoxemic respiratory failure.</p><p><strong>Methods: </strong>In this prespecified analysis of a randomized trial of helmet NIV versus high-flow nasal oxygen (HENIVOT), clinical status, physical performance (6-min-walking-test and 30-s chair stand test), respiratory function and quality of life (EuroQoL five dimensions five levels questionnaire, EuroQoL VAS, SF36 and Post-Traumatic Stress Disorder Checklist for the DSM) were evaluated 6 months after the enrollment.</p><p><strong>Results: </strong>Among 80 patients who were alive, 71 (89%) completed the follow-up: 35 had received helmet NIV, 36 high-flow oxygen. There was no inter-group difference in any item concerning vital signs (N = 4), physical performance (N = 18), respiratory function (N = 27), quality of life (N = 21) and laboratory tests (N = 15). Arthralgia was significantly lower in the helmet group (16% vs. 55%, p = 0.002). Fifty-two percent of patients in helmet group vs. 63% of patients in high-flow group had diffusing capacity of the lungs for carbon monoxide < 80% of predicted (p = 0.44); 13% vs. 22% had forced vital capacity < 80% of predicted (p = 0.51). Both groups reported similar degree of pain (p = 0.81) and anxiety (p = 0.81) at the EQ-5D-5L test; the EQ-VAS score was similar in the two groups (p = 0.27). Compared to patients who successfully avoided invasive mechanical ventilation (54/71, 76%), intubated patients (17/71, 24%) had significantly worse pulmonary function (median diffusing capacity of the lungs for carbon monoxide 66% [Interquartile range: 47-77] of predicted vs. 80% [71-88], p = 0.005) and decreased quality of life (EQ-VAS: 70 [53-70] vs. 80 [70-83], p = 0.01).</p><p><strong>Conclusions: </strong>In patients with COVID-19 hypoxemic respiratory failure, treatment with helmet NIV or high-flow oxygen yielded similar quality of life and functional outcome at 6 months. The need for invasive mechanical ventilation was associated with worse outcomes. These data indicate that helmet NIV, as applied in the HENIVOT trial, can be safely used in hypoxemic patients. Trial registration Registered on clinicaltrials.gov NCT04502576 on August 6, 2020.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9497537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of a preoperative nurse-led orientation program on postoperative delirium after cardiovascular surgery: a retrospective single-center observational study. 术前护士指导对心血管手术后谵妄的影响:一项回顾性单中心观察性研究。
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-17 DOI: 10.1186/s40560-023-00666-3
Ryo Nakamura, Kyohei Miyamoto, Kaori Tsuji, Kana Ozaki, Hideki Kunimoto, Kentaro Honda, Yoshiharu Nishimura, Seiya Kato

Background: Postoperative delirium in intensive care is common and associated with mortality, cognitive impairment, prolonged hospital stays and high costs. We evaluate whether a nurse-led orientation program could reduce the incidence of delirium in the intensive care unit after cardiovascular surgery.

Methods: In this retrospective cohort study, we enrolled patients admitted to the intensive care unit for planned cardiovascular surgery between January 2020 and December 2021. A nurse-led orientation program based on a preoperative visit was routinely introduced from January 2021. We assessed the association between these visits and postoperative delirium in the intensive care unit. We also assessed predictors of postoperative delirium with baseline and intraoperative characteristics.

Results: Among 253 patients with planned cardiovascular surgery, 128 (50.6%) received preoperative visits. Valve surgery comprised 44.7%, coronary surgery 31.6%, and aortic surgery 20.9%. Cardiopulmonary bypass use and transcatheter surgery were 60.5% and 12.3%, respectively. Incidence of delirium was lower in patients that received preoperative visits, and median hospital stay was shorter than in those without visits (18 patients [14.1%] vs 34 patients [27.2%], P < 0.01; 14 days vs 17 days, P < 0.01). After adjusting predefined confounders, preoperative visits were independently associated with decreased incidence of delirium (adjusted odds ratio [aOR] 0.45; 95% confidence interval [95% CI] 0.22-0.84). Other predictors of delirium were higher European System for Cardiac Operative Risk Evaluation II score and lower minimum intraoperative cerebral oxygen saturation.

Conclusions: A preoperative nurse-led orientation program was associated with reduction of postoperative delirium and could be effective against postoperative delirium after cardiovascular surgery. Trial registration UMIN Clinical Trial Registry no. UMIN000048142. Registered 22, July, 2022, retrospectively registered, https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000054862 .

背景:重症监护术后谵妄很常见,与死亡率、认知功能障碍、住院时间延长和费用高有关。我们评估一个护士主导的定向项目是否可以减少心血管手术后重症监护病房谵妄的发生率。方法:在这项回顾性队列研究中,我们纳入了2020年1月至2021年12月期间因计划心血管手术而入住重症监护病房的患者。从2021年1月起,常规引入了基于术前访问的护士主导的培训计划。我们评估了这些访问与重症监护室术后谵妄之间的关系。我们还通过基线和术中特征评估了术后谵妄的预测因素。结果:253例计划行心血管手术患者中,术前访视128例(50.6%)。瓣膜手术占44.7%,冠状动脉手术占31.6%,主动脉手术占20.9%。体外循环和经导管手术分别占60.5%和12.3%。术前就诊的患者谵妄的发生率较低,住院时间中位数比未就诊的患者短(18例[14.1%]vs 34例[27.2%])。结论:术前护士引导的指导计划与减少术后谵妄有关,可有效预防心血管手术后谵妄。临床试验注册编号:UMIN000048142。注册日期:2022年7月22日,追溯注册,https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000054862。
{"title":"The impact of a preoperative nurse-led orientation program on postoperative delirium after cardiovascular surgery: a retrospective single-center observational study.","authors":"Ryo Nakamura,&nbsp;Kyohei Miyamoto,&nbsp;Kaori Tsuji,&nbsp;Kana Ozaki,&nbsp;Hideki Kunimoto,&nbsp;Kentaro Honda,&nbsp;Yoshiharu Nishimura,&nbsp;Seiya Kato","doi":"10.1186/s40560-023-00666-3","DOIUrl":"https://doi.org/10.1186/s40560-023-00666-3","url":null,"abstract":"<p><strong>Background: </strong>Postoperative delirium in intensive care is common and associated with mortality, cognitive impairment, prolonged hospital stays and high costs. We evaluate whether a nurse-led orientation program could reduce the incidence of delirium in the intensive care unit after cardiovascular surgery.</p><p><strong>Methods: </strong>In this retrospective cohort study, we enrolled patients admitted to the intensive care unit for planned cardiovascular surgery between January 2020 and December 2021. A nurse-led orientation program based on a preoperative visit was routinely introduced from January 2021. We assessed the association between these visits and postoperative delirium in the intensive care unit. We also assessed predictors of postoperative delirium with baseline and intraoperative characteristics.</p><p><strong>Results: </strong>Among 253 patients with planned cardiovascular surgery, 128 (50.6%) received preoperative visits. Valve surgery comprised 44.7%, coronary surgery 31.6%, and aortic surgery 20.9%. Cardiopulmonary bypass use and transcatheter surgery were 60.5% and 12.3%, respectively. Incidence of delirium was lower in patients that received preoperative visits, and median hospital stay was shorter than in those without visits (18 patients [14.1%] vs 34 patients [27.2%], P < 0.01; 14 days vs 17 days, P < 0.01). After adjusting predefined confounders, preoperative visits were independently associated with decreased incidence of delirium (adjusted odds ratio [aOR] 0.45; 95% confidence interval [95% CI] 0.22-0.84). Other predictors of delirium were higher European System for Cardiac Operative Risk Evaluation II score and lower minimum intraoperative cerebral oxygen saturation.</p><p><strong>Conclusions: </strong>A preoperative nurse-led orientation program was associated with reduction of postoperative delirium and could be effective against postoperative delirium after cardiovascular surgery. Trial registration UMIN Clinical Trial Registry no. UMIN000048142. Registered 22, July, 2022, retrospectively registered, https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000054862 .</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9495366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study. 重症医师覆盖率和COVID-19危重患者结局:一项基于人群的队列研究
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-12 DOI: 10.1186/s40560-023-00668-1
Tak Kyu Oh, Saeyeon Kim, In-Ae Song

Background: Trained intensivist staffing improves survival outcomes in critically ill patients at intensive care units. However, the impact on outcomes of critically ill patients with coronavirus disease 2019 has not yet been evaluated. We aimed to investigate whether trained intensivists affect outcomes among critically ill coronavirus disease 2019 patients in South Korean intensive care units.

Methods: Using a nationwide registration database in South Korea, we included adult patients admitted to the intensive care unit from October 8, 2020, to December 31, 2021, with a main diagnosis of coronavirus disease 2019. Critically ill patients admitted to intensive care units that employed trained intensivists were included in the intensivist group, whereas all other critically ill patients were assigned to the non-intensivist group.

Results: A total of 13,103 critically ill patients were included, with 2653 (20.2%) patients in the intensivist group and 10,450 (79.8%) patients in the non-intensivist group. In the covariate-adjusted multivariable logistic regression model, the intensivist group exhibited 28% lower in-hospital mortality than that of the non-intensivist group (odds ratio: 0.72; 95% confidence interval: 0.62, 0.83; P < 0.001).

Conclusions: Trained intensivist coverage was associated with lower in-hospital mortality among critically ill coronavirus disease 2019 patients who required intensive care unit admission in South Korea.

背景:训练有素的重症监护人员可以改善重症监护病房危重患者的生存结果。然而,对2019冠状病毒病危重患者预后的影响尚未得到评估。我们的目的是调查训练有素的重症医师是否会影响韩国重症监护室2019冠状病毒病危重患者的预后。方法:使用韩国全国登记数据库,纳入了2020年10月8日至2021年12月31日期间入住重症监护病房的成年患者,主要诊断为2019冠状病毒病。入住重症监护病房的危重患者被纳入重症监护组,而所有其他危重患者被分配到非重症监护组。结果:共纳入危重患者13103例,其中重症监护组2653例(20.2%),非重症监护组10450例(79.8%)。在协变量校正的多变量logistic回归模型中,重症监护组的住院死亡率比非重症监护组低28%(优势比:0.72;95%置信区间:0.62,0.83;结论:在韩国,训练有素的重症医师覆盖率与需要入住重症监护病房的2019年冠状病毒病危重患者住院死亡率降低有关。
{"title":"Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study.","authors":"Tak Kyu Oh,&nbsp;Saeyeon Kim,&nbsp;In-Ae Song","doi":"10.1186/s40560-023-00668-1","DOIUrl":"https://doi.org/10.1186/s40560-023-00668-1","url":null,"abstract":"<p><strong>Background: </strong>Trained intensivist staffing improves survival outcomes in critically ill patients at intensive care units. However, the impact on outcomes of critically ill patients with coronavirus disease 2019 has not yet been evaluated. We aimed to investigate whether trained intensivists affect outcomes among critically ill coronavirus disease 2019 patients in South Korean intensive care units.</p><p><strong>Methods: </strong>Using a nationwide registration database in South Korea, we included adult patients admitted to the intensive care unit from October 8, 2020, to December 31, 2021, with a main diagnosis of coronavirus disease 2019. Critically ill patients admitted to intensive care units that employed trained intensivists were included in the intensivist group, whereas all other critically ill patients were assigned to the non-intensivist group.</p><p><strong>Results: </strong>A total of 13,103 critically ill patients were included, with 2653 (20.2%) patients in the intensivist group and 10,450 (79.8%) patients in the non-intensivist group. In the covariate-adjusted multivariable logistic regression model, the intensivist group exhibited 28% lower in-hospital mortality than that of the non-intensivist group (odds ratio: 0.72; 95% confidence interval: 0.62, 0.83; P < 0.001).</p><p><strong>Conclusions: </strong>Trained intensivist coverage was associated with lower in-hospital mortality among critically ill coronavirus disease 2019 patients who required intensive care unit admission in South Korea.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9468853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the efficacy and comfort of high-flow nasal cannula with different initial flow settings in patients with acute hypoxemic respiratory failure: a systematic review and network meta-analysis. 不同初始流量设置的高流量鼻插管治疗急性低氧性呼吸衰竭的疗效和舒适度比较:系统综述和网络荟萃分析
IF 7.1 2区 医学 Q1 Medicine Pub Date : 2023-05-10 DOI: 10.1186/s40560-023-00667-2
Yuewen He, Xuhui Zhuang, Hao Liu, Wuhua Ma

Background: High-flow nasal cannula (HFNC) has been proven effective in improving patients with acute hypoxemic respiratory failure (AHRF), but a discussion of its use for initial flow settings still need to be provided. We aimed to compare the effectiveness and comfort evaluation of HFNC with different initial flow settings in patients with AHRF.

Methods: Studies published by October 10, 2022, were searched exhaustively in PubMed, Embase, Web of Science, Cochrane Library (CENTRAL), and the China National Knowledge Infrastructure (CNKI) database. Network meta-analysis (NMA) was performed with STATA 17.0 and R software (version 4.2.1). A Bayesian framework was applied for this NMA. Comparisons of competing models based on the deviance information criterion (DIC) were used to select the best model for NMA. The primary outcome is the intubation at day 28. Secondary outcomes included short-term and long-term mortality, comfort score, length of ICU or hospital stay, and 24-h PaO2/FiO2.

Results: This NMA included 23 randomized controlled trials (RCTs) with 5774 patients. With NIV as the control, the HFNC_high group was significantly associated with lower intubation rates (odds ratio [OR] 0.72 95% credible interval [CrI] 0.56 to 0.93; moderate quality evidence) and short-term mortality (OR 0.81 95% CrI 0.69 to 0.96; moderate quality evidence). Using HFNC_Moderate (Mod) group (mean difference [MD] - 1.98 95% CrI -3.98 to 0.01; very low quality evidence) as a comparator, the HFNC_Low group had a slight advantage in comfort scores but no statistically significant difference. Of all possible interventions, the HFNC_High group had the highest probability of being the best in reducing intubation rates (73.04%), short-term (82.74%) and long-term mortality (67.08%). While surface under the cumulative ranking curve value (SUCRA) indicated that the HFNC_Low group had the highest probability of being the best in terms of comfort scores.

Conclusions: The high initial flow settings (50-60 L/min) performed better in decreasing the occurrence of intubation and mortality, albeit with poor comfort scores. Treatment of HFNC for AHRF patients ought to be initiated from moderate flow rates (30-40 L/min), and individualized flow settings can make HFNC more sensible in clinical practice.

背景:高流量鼻插管(HFNC)已被证明对改善急性低氧性呼吸衰竭(AHRF)患者有效,但其用于初始流量设置的讨论仍需提供。我们的目的是比较不同初始流量设置的HFNC对AHRF患者的有效性和舒适度评估。方法:全面检索PubMed、Embase、Web of Science、Cochrane Library (CENTRAL)和中国知网(CNKI)数据库中2022年10月10日前发表的研究。采用STATA 17.0软件和4.2.1版本的R软件进行网络meta分析(NMA)。该NMA采用贝叶斯框架。基于偏差信息准则(DIC),比较了竞争模型,选择了最佳的NMA模型。主要结局是第28天插管。次要结局包括短期和长期死亡率、舒适评分、ICU或住院时间、24小时PaO2/FiO2。结果:该NMA纳入了23项随机对照试验(RCTs), 5774例患者。以NIV为对照,HFNC_high组与较低插管率显著相关(优势比[OR] 0.72 95%可信区间[CrI] 0.56 ~ 0.93;中等质量证据)和短期死亡率(OR 0.81 95% CrI 0.69 ~ 0.96;中等质量证据)。采用HFNC_Moderate (Mod)组(mean difference [MD] - 1.98 95% CrI -3.98至0.01;非常低质量证据)作为比较,HFNC_Low组在舒适评分上有轻微优势,但没有统计学上的显著差异。在所有可能的干预措施中,HFNC_High组在降低插管率(73.04%)、短期(82.74%)和长期死亡率(67.08%)方面的成功率最高。而累积排名曲线值(SUCRA)下的曲面显示HFNC_Low组在舒适度得分上获得最佳的概率最高。结论:高初始流量设置(50-60 L/min)在降低插管发生率和死亡率方面表现较好,尽管舒适性评分较差。AHRF患者的HFNC治疗应从中等流量(30-40 L/min)开始,个体化的流量设置可以使HFNC在临床实践中更加合理。
{"title":"Comparison of the efficacy and comfort of high-flow nasal cannula with different initial flow settings in patients with acute hypoxemic respiratory failure: a systematic review and network meta-analysis.","authors":"Yuewen He,&nbsp;Xuhui Zhuang,&nbsp;Hao Liu,&nbsp;Wuhua Ma","doi":"10.1186/s40560-023-00667-2","DOIUrl":"https://doi.org/10.1186/s40560-023-00667-2","url":null,"abstract":"<p><strong>Background: </strong>High-flow nasal cannula (HFNC) has been proven effective in improving patients with acute hypoxemic respiratory failure (AHRF), but a discussion of its use for initial flow settings still need to be provided. We aimed to compare the effectiveness and comfort evaluation of HFNC with different initial flow settings in patients with AHRF.</p><p><strong>Methods: </strong>Studies published by October 10, 2022, were searched exhaustively in PubMed, Embase, Web of Science, Cochrane Library (CENTRAL), and the China National Knowledge Infrastructure (CNKI) database. Network meta-analysis (NMA) was performed with STATA 17.0 and R software (version 4.2.1). A Bayesian framework was applied for this NMA. Comparisons of competing models based on the deviance information criterion (DIC) were used to select the best model for NMA. The primary outcome is the intubation at day 28. Secondary outcomes included short-term and long-term mortality, comfort score, length of ICU or hospital stay, and 24-h PaO<sub>2</sub>/FiO<sub>2</sub>.</p><p><strong>Results: </strong>This NMA included 23 randomized controlled trials (RCTs) with 5774 patients. With NIV as the control, the HFNC_high group was significantly associated with lower intubation rates (odds ratio [OR] 0.72 95% credible interval [CrI] 0.56 to 0.93; moderate quality evidence) and short-term mortality (OR 0.81 95% CrI 0.69 to 0.96; moderate quality evidence). Using HFNC_Moderate (Mod) group (mean difference [MD] - 1.98 95% CrI -3.98 to 0.01; very low quality evidence) as a comparator, the HFNC_Low group had a slight advantage in comfort scores but no statistically significant difference. Of all possible interventions, the HFNC_High group had the highest probability of being the best in reducing intubation rates (73.04%), short-term (82.74%) and long-term mortality (67.08%). While surface under the cumulative ranking curve value (SUCRA) indicated that the HFNC_Low group had the highest probability of being the best in terms of comfort scores.</p><p><strong>Conclusions: </strong>The high initial flow settings (50-60 L/min) performed better in decreasing the occurrence of intubation and mortality, albeit with poor comfort scores. Treatment of HFNC for AHRF patients ought to be initiated from moderate flow rates (30-40 L/min), and individualized flow settings can make HFNC more sensible in clinical practice.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":null,"pages":null},"PeriodicalIF":7.1,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9456185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Intensive Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1